The effects of taurine on atherosclerosis development in cholesterol-fed rabbits.
Level 5 - mechanism / opinion, no new human data
Animal experiment (cholesterol-fed rabbit model)
PubMed 2364997 · doi:10.1016/0014-2999(90)90599-2
What was done
Rabbits were maintained on a 2% cholesterol diet for 14 weeks while receiving taurine (0.2% or 0.5%) in drinking water or acting as controls. Authors measured thoracic aorta atherosclerotic lesion coverage, serum and tissue concentrations of cholesterol, calcium, triglycerides, and phospholipids, as well as blood pressure and dP/dtmax.
What was found
Taurine significantly reduced the thoracic aorta area covered by atherosclerotic lesions to 58 ± 15% (0.2% taurine) and 52.5 ± 12% (0.5% taurine) compared with 72.4 ± 19% in the control group (P < 0.05). Taurine had no significant effect on serum or tissue cholesterol, calcium, triglyceride, or phospholipid concentrations. Taurine at 0.2% increased dP/dtmax, while 0.5% taurine lowered systemic blood pressure.
Why it matters
The findings show that taurine can limit experimental atherosclerotic lesion development independently of changes in serum lipid profiles or blood pressure reduction, pointing toward alternative pathways such as antioxidant mechanisms.
Limits
This is an animal study in hypercholesterolemic rabbits and cannot be directly generalized to humans. The abstract does not report the total sample size (n) or group sizes, and antioxidant activity was only discussed rather than directly quantified.
Cited by
- supports In rabbits fed a 2% cholesterol diet for 14 weeks, roughly 72% of the thoracic aorta was covered in lesions, which was reduced to 58% at a lower taurine dose and 52% at a higher taurine dose in drinking water.
- supports In rabbits fed a 2% cholesterol diet, taurine supplementation reduced aortic lesion size without significantly affecting serum or tissue cholesterol levels.